325 related articles for article (PubMed ID: 19331853)
1. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles.
Nam HY; Kwon SM; Chung H; Lee SY; Kwon SH; Jeon H; Kim Y; Park JH; Kim J; Her S; Oh YK; Kwon IC; Kim K; Jeong SY
J Control Release; 2009 May; 135(3):259-67. PubMed ID: 19331853
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery.
Yoo HS; Lee JE; Chung H; Kwon IC; Jeong SY
J Control Release; 2005 Mar; 103(1):235-43. PubMed ID: 15710514
[TBL] [Abstract][Full Text] [Related]
3. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
Kim JH; Kim YS; Kim S; Park JH; Kim K; Choi K; Chung H; Jeong SY; Park RW; Kim IS; Kwon IC
J Control Release; 2006 Mar; 111(1-2):228-34. PubMed ID: 16458988
[TBL] [Abstract][Full Text] [Related]
4. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles.
Park K; Kim JH; Nam YS; Lee S; Nam HY; Kim K; Park JH; Kim IS; Choi K; Kim SY; Kwon IC
J Control Release; 2007 Oct; 122(3):305-14. PubMed ID: 17643545
[TBL] [Abstract][Full Text] [Related]
5. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release.
Park JS; Han TH; Lee KY; Han SS; Hwang JJ; Moon DH; Kim SY; Cho YW
J Control Release; 2006 Sep; 115(1):37-45. PubMed ID: 16935380
[TBL] [Abstract][Full Text] [Related]
6. Characterization of folate-chitosan-DNA nanoparticles for gene therapy.
Mansouri S; Cuie Y; Winnik F; Shi Q; Lavigne P; Benderdour M; Beaumont E; Fernandes JC
Biomaterials; 2006 Mar; 27(9):2060-5. PubMed ID: 16202449
[TBL] [Abstract][Full Text] [Related]
7. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
[TBL] [Abstract][Full Text] [Related]
8. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles.
Bravo-Osuna I; Schmitz T; Bernkop-Schnürch A; Vauthier C; Ponchel G
Int J Pharm; 2006 Jun; 316(1-2):170-5. PubMed ID: 16580797
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM
Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575
[TBL] [Abstract][Full Text] [Related]
10. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
Gan Q; Wang T; Cochrane C; McCarron P
Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
[TBL] [Abstract][Full Text] [Related]
11. Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes.
Dinauer N; Balthasar S; Weber C; Kreuter J; Langer K; von Briesen H
Biomaterials; 2005 Oct; 26(29):5898-906. PubMed ID: 15949555
[TBL] [Abstract][Full Text] [Related]
12. Polymeric micelles with glycolipid-like structure and multiple hydrophobic domains for mediating molecular target delivery of paclitaxel.
You J; Hu FQ; Du YZ; Yuan H
Biomacromolecules; 2007 Aug; 8(8):2450-6. PubMed ID: 17661518
[TBL] [Abstract][Full Text] [Related]
13. Development and characterisation of chitosan nanoparticles for siRNA delivery.
Katas H; Alpar HO
J Control Release; 2006 Oct; 115(2):216-25. PubMed ID: 16959358
[TBL] [Abstract][Full Text] [Related]
14. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery?
Martien R; Loretz B; Thaler M; Majzoob S; Bernkop-Schnürch A
J Biomed Mater Res A; 2007 Jul; 82(1):1-9. PubMed ID: 17265441
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex.
Cafaggi S; Russo E; Stefani R; Leardi R; Caviglioli G; Parodi B; Bignardi G; De Totero D; Aiello C; Viale M
J Control Release; 2007 Aug; 121(1-2):110-23. PubMed ID: 17601625
[TBL] [Abstract][Full Text] [Related]
16. Tuning of shell and core characteristics of chitosan-decorated acrylic nanoparticles.
Bravo-Osuna I; Ponchel G; Vauthier C
Eur J Pharm Sci; 2007 Feb; 30(2):143-54. PubMed ID: 17157487
[TBL] [Abstract][Full Text] [Related]
17. Linolenic acid-modified chitosan for formation of self-assembled nanoparticles.
Liu CG; Desai KG; Chen XG; Park HJ
J Agric Food Chem; 2005 Jan; 53(2):437-41. PubMed ID: 15656685
[TBL] [Abstract][Full Text] [Related]
18. Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol).
Zahr AS; Davis CA; Pishko MV
Langmuir; 2006 Sep; 22(19):8178-85. PubMed ID: 16952259
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity.
Hyung Park J; Kwon S; Lee M; Chung H; Kim JH; Kim YS; Park RW; Kim IS; Bong Seo S; Kwon IC; Young Jeong S
Biomaterials; 2006 Jan; 27(1):119-26. PubMed ID: 16023198
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.
Kohler N; Sun C; Wang J; Zhang M
Langmuir; 2005 Sep; 21(19):8858-64. PubMed ID: 16142971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
